×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Tracking Misuse and Abuse of Marketed Products: Is Pharma Doing All that It Can?
Session Chair(s)
Mitch Miller, PharmD
Director, Publications and Medical Writing
Ashfield Pharmacovigilance, United States
Faster, Higher, Stronger: The Biopharmaceutical Industry’s Collaboration Against Doping Abuse of Medicines in Sport
Learning Objective : Identify the current methods of tracking misuse and abuse of marketed pharmaceuticals; Explain the role of REMS with regard to misuse and abuse; Identify best practices in the communication of risks involved in handling and/or incorrectly using a controlled substance .
Speaker(s)
Faster, Higher, Stronger: The Biopharmaceutical Industry’s Collaboration Against Doping Abuse of Medicines in Sport
Barbara Leishman
F. Hoffmann-La Roche Ltd., Switzerland
Data Sources for Monitoring Usage of Drug Products and Supporting Safety and REMS Evaluations
Juliane Mills, MPH, MSc, MT
PRA Health Sciences, United States
Director Scientific Affairs, Real World Solutions
Use of Serialization/Track and Trace Technologies
Rick L. Seibert, MBA, MS, PMP
Sharp Corporation, United States
Vice President, Project Management and New Business Development and Engineering
Have an account?